Podcast 25: Top 10 Watch List: Pharma CEOs on the Rise

In this podcast we feature a list of the Top 10 pharma CEOs to watch in 2020.

Key topics: (see Chapter Markers)

  • Pharma CEOs to watch in 2020
  • 1. Three-way tie: Pfizer, J&J, and AstraZeneca.
  • Pfizer Chairman and CEO Albert Bourla
  • J&J Chairman and CEO Alex Gorsky
  • AstraZeneca CEO Pascal Soriot
  • 4. Moderna CEO Stéphane Bancel
  • 5. Gilead Sciences Chairman and CEO Daniel O’Day
  • 6. Regeneron Pharmaceuticals Co-Founder, President and CEO Leonard S. Schleifer
  • 7 (tie). CureVac CEO Franz-Werner Haas and Novavax CEO and President Stanley C. Erck
  • 9. Seagen (formerly Seattle Genetics) President, CEO and Chairman Clay Siegall
  • 10. Genmab CEO Jan G. J. van de Winkel

Sponsor: LabVantage Solutions

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Podcast 44: What’s Trending: Parenteral Drug Development & Manufacturing

What are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights…

Podcast 43: CDMOs/CMOs: The Movers and Shakers of 2023

As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the…

Podcast 42: CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023 

As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an…

Podcast 41: API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains 

The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages…